Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010725 · ClinicalTrials.gov registry record · Phase 2
Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks
A Phase 2 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 138
- Enrollment target
NCT00010725 is a Phase 2 study that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 138 participants.
The verdict
NCT00010725, a Phase 2 study, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 138 participants
- Enrollment target
Study Summary
The purpose of this study is to compare an herbal supplement, nonfood-derived vitamins, and placebo for the care of cardiovascular disease in high risk older African Americans.
Interventions
- DRUG MAK
- DRUG Vitamin Supplements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 1999-09 |
| Est. Completion | 2004-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00010725
The ClinicalTrials.gov registry entry for NCT00010725 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MAK is the first listed.
NCT00010725 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00010725 about?
NCT00010725 is a clinical study titled "Effects of Herbal Antioxidants on Cardiovascular Disease in Older Blacks". The purpose of this study is to compare an herbal supplement, nonfood-derived vitamins, and placebo for the care of cardiovascular disease in high risk older African Americans.
What is the current status of trial NCT00010725?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 138 participants. The study started on 1999-09. Estimated completion is 2004-08.
What interventions are being tested in trial NCT00010725?
The interventions under investigation include: MAK (DRUG), Vitamin Supplements (DRUG).
Who is sponsoring clinical trial NCT00010725?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.